SARS-CoV-2 Omicron Antibody Biotinylated

<strong>SARS-CoV-2 Omicron Antibody Biotinylated</strong>_x000D_ <strong>Catalog number:</strong> B2010664_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> molecular tool for the research and development of SARS-CoV-2 Omicron assays_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> SARS-CoV-2 Spike Antibody biotin, Omicron Antibody biotin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2022/03/MKT-010-SARS-CoV-2-Brochure-Rev-A.pdf">Download SARS-CoV-2 Brochure</a>_x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, Hossain MG. Omicron_x000D_ variant of SARS-CoV-2: Genomics, transmissibility, and responses to current_x000D_ COVID-19 vaccines. J Med Virol. 2022 Jan 12._x000D_ _x000D_ 2: Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML,_x000D_ Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ,_x000D_ Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. mRNA-based_x000D_ COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2_x000D_ Omicron variant. Cell. 2022 Feb 3;185(3):457-466.e4._x000D_ _x000D_ 3: He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 Omicron variant: Characteristics_x000D_ and prevention. MedComm (2020). 2021 Dec 16;2(4):838–45._x000D_ _x000D_ 4: Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C._x000D_ Omicron SARS-CoV-2 variant: What we know and what we don't. Anaesth Crit Care_x000D_ Pain Med. 2022 Feb;41(1):100998._x000D_ _x000D_ 5: Gao SJ, Guo H, Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global_x000D_ urgent public health alert! J Med Virol. 2022 Apr;94(4):1255-1256._x000D_ _x000D_ 6: Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the_x000D_ COVID-19 pandemic. Lancet. 2021 Dec 11;398(10317):2126-2128._x000D_ _x000D_ 7: Thakur V, Ratho RK. OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern_x000D_ mounting worldwide fear. J Med Virol. 2021 Dec 22._x000D_ _x000D_ 8: Zhang L, Li Q, Liang Z, Li T, Liu S, Cui Q, Nie J, Wu Q, Qu X, Huang W, Wang_x000D_ Y. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron._x000D_ Emerg Microbes Infect. 2022 Dec;11(1):1-5._x000D_ _x000D_ 9: Gu H, Krishnan P, Ng DYM, Chang LDJ, Liu GYZ, Cheng SSM, Hui MMY, Fan MCY,_x000D_ Wan JHL, Lau LHK, Cowling BJ, Peiris M, Poon LLM. Probable Transmission of SARS-_x000D_ CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021._x000D_ Emerg Infect Dis. 2022 Feb;28(2):460-462._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34874638/">10: Rubin EJ, Baden LR, Abdool Karim SS, Morrissey S. Audio Interview: The</a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Omicron Antibody Biotinylated</strong><a href="https://moleculardepot.com/product-category/Antibodies/">: Antibodies</a>